Gurpreet Kaur, FNP-BC

Gurpreet Kaur practices at Skyline Healthcare Center - San Jose in San Jose, California.

Gurpreet Kaur's NPI, 1275229379, was assigned on April 12, 2023. Gurpreet Kaur holds California license NP95024636.

Gurpreet Kaur's primary practice is Skyline Healthcare Center - San Jose, at 2065 Forest Avenue, San Jose, CA 95128 in Santa Clara County. The practice phone is (408) 280-2500.

Gurpreet Kaur's primary practice is Skyline Healthcare Center - San Jose in San Jose, California. The medical group on file is County of Santa Clara Behavioral Health Services, Las Plumas Behavioral Health Clinic. Dmand AI also links Gurpreet Kaur to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gurpreet Kaur practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Gurpreet Kaur's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Gurpreet Kaur is licensed in California.

Dmand AI lists anxiety, arthritis, asthma, bipolar disorder, chronic diabetes, chronic kidney disease, chronic obstructive pulmonary disease (COPD) and chronic respiratory failure among the conditions Gurpreet Kaur treats.

CMS data shows 6,316 Medicare services from Gurpreet Kaur across 5 procedure codes in 2024, for 825 Medicare patients. Medicare paid $490,559 for them. Every service was in an office.

CMS counts 825 Medicare patients who saw Gurpreet Kaur in 2024. The largest group is 75 to 84, with 278 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 58% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gurpreet Kaur's median patient age at 75, with 50% women.

In 2024, Gurpreet Kaur wrote 1,142 Medicare Part D claims for 213 patients. 84% of them were for generic drugs. CMS names the drug for 729 of them, across 33 drugs with 11 or more claims each, at $55,035 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 17 out of 100 for Gurpreet Kaur for performance year 2024, reported individually. Gurpreet Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Gurpreet Kaur from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $41.